This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07967/identifier/pubchem-compound/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07967/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07967/identifier/drugbank/
n8http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07967/identifier/chemspider/
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB07967/identifier/pdb/

Statements

Subject Item
n2:DB07967
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB07967 n8:DB07967
dcterms:title
9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE
adms:identifier
n10:DB07967 n11:IHI n12:9639366 n13:11464526 n14:99444438
n5:IUPAC-Name
n6:271B50F4-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B50FA-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B50F9-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B50F6-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B50F7-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B50F8-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B50F2-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B50F0-363D-11E5-9242-09173F13E4C5 n6:271B50F3-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B50F1-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5100-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5101-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B50FB-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B50FC-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B50FE-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B50FD-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B50FF-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5106-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5108-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5109-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5105-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5104-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5107-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B50F5-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5102-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5103-363D-11E5-9242-09173F13E4C5